Related Experiment Video
Updated: Apr 6, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
[The Regulatory Proteins of β-Adrenergic Receptor and Their Functions]
Insights
Cardiovascular diseases are a major health threat. Beta-adrenergic receptors are key drug targets, with function-selective ligands offering new therapeutic opportunities for cardiovascular disease treatment.
Area of Science:
- Cardiovascular biology and pharmacology
- G protein-coupled receptor signaling
Background:
- Vascular diseases are a leading cause of mortality.
- Beta-adrenergic receptors (β-ARs) are crucial targets for cardiovascular drugs.
- β-AR blockers represent a significant advancement in cardiovascular disease treatment.
Purpose of the Study:
- To review signaling pathways and functions of β-adrenergic receptor regulatory proteins.
- To highlight the potential of function-selective ligands in drug discovery for cardiovascular diseases.
Main Methods:
- Literature review of β-adrenergic receptor research.
- Analysis of signaling pathways and regulatory proteins.
Main Results:
- β-adrenergic receptors are precisely regulated by various proteins in cellular signaling.
- Function-selective ligands are emerging as a promising area in receptor research.
Conclusions:
- Understanding β-AR regulatory proteins is vital for cardiovascular disease research.
- Function-selective ligands offer novel therapeutic avenues for cardiovascular conditions.
Abstract:
Vascular diseases has become a top killer of human health, and cardiovascular receptors are pivotal in the occurrence, development, prevention and treatment of cardiovascular diseases. As for the important member of G protein-coupled receptor, β-adrenergic receptor is undoubtedly a most important target of cardiovascular drugs. Being the hot spot in the cardiovascular research and application, β- adrenergic receptor blocker has been considered as the greatest breakthrough for the prevention and cure of cardiovascular disease after digitalis. The 2012 Nobel Prize in chemistry was awarded again to the researchers on β-adrenergic receptors. Extensive researchs show that β-adrenergic receptors are precisely regulated by different regulatory proteins in cells in the transduction of different physiological and pathological signaling pathways. Based on these findings, function-selective ligands recently arise in the receptor research and will be the new chance of drug discovery. In this article we reviewed the related signal pathways and functions of β-adrenergic receptor regulatory proteins.
Related Concept Videos
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Antihypertensive Drugs: Types of β-Blockers
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

